Related Experiment Video
Updated: Apr 16, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
1.5K
Rituximab and Acute Retinal Necrosis in a Patient with Scleromalacia and Rheumatoid Arthritis.
Sarah Schuler1, Matthias Brunner1, Wolfgang Bernauer1,2
1a ÓMMA Eye Center , Zurich , Switzerland and.
Ocular Immunology and Inflammation
|March 12, 2015
Summary
Rituximab, used for autoimmune diseases, may increase the risk of acute retinal necrosis. This case report highlights a potential link between rituximab therapy and this severe viral infection in patients with rheumatoid scleromalacia.
Area of Science:
- Ophthalmology
- Rheumatology
- Immunology
Background:
- Rituximab is a biologic agent effective in treating vasculitis.
- Immunosuppressive therapies carry risks of severe complications.
Observation:
- A patient with rheumatoid arthritis and progressive scleromalacia developed acute retinal necrosis.
- The patient was undergoing therapy with rituximab.
Findings:
- This case demonstrates a potential correlation between rituximab treatment and acute retinal necrosis.
- This is the first reported instance linking rituximab to acute retinal necrosis in rheumatoid scleromalacia.
Implications:
- Rituximab, while beneficial for autoimmune conditions, may trigger viral infections.
- Awareness of potential rituximab-associated complications like acute retinal necrosis is crucial for patient management.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
820
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
820
01:21Rheumatic Heart Disease III: Medical Management
523
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
523
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
726
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
726
01:20Rheumatic Heart Disease IV: Nursing Management
469
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
469
01:23Rheumatic Heart Disease I: Introduction
975
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
975
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.2K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K